What is NIPT Test?
NIPT is a simple, safe, and non invasive prenatal screening test that provides assurance to expectant parents with accurate genetic information about their babyNIPT Test uses advanced bioinformatics technology to evaluate fetal DNA (of placental origin) in maternal blood to identify genetic variations leading to disorders.
What are the conditions that NIPT, NIPT Twins, and NIPT Advanced can detect?
NIPT can detect common Aneuploidies and Sex Chromosome Abnormalities.
NIPT
Trisomy 21 (Down Syndrome)
Trisomy 18 (Edwards’ Syndrome)
Trisomy 13 (Patau syndrome)
Turner Syndrome (Monosomy X/XO)
Klinefelter Syndrome (XXY)
Triple X (XXX)
Jacob’s Syndrome (XYY)
NIPT Advanced
Rare Autosomal Aneuploidies (RAA) include trisomies in chromosomes other than 21, 18 and 13 and monosomies in all 22 chromosomes.
NIPT Advanced screens for RAAs in addition to Trisomy 13, 18, 21 and sex chromosomes.
NIPT Twins
Trisomy 21
Trisomy 18
Trisomy 13
Here’s a more detailed explanation:
NIPT (Non-Invasive Prenatal Testing):This is the most common and widely used term for the test.
NIPS (Non-Invasive Prenatal Screening):Some healthcare professionals and organizations prefer this term, as NIPT is a screening test, not a diagnostic test.
cfDNA (cell-free DNA) screening:This term refers to the type of DNA analyzed in the test, which is the DNA fragments circulating in the pregnant woman’s blood.
₹12,000.00Original price was: ₹12,000.00.₹9,000.00Current price is: ₹9,000.00.
N-terminal precursor of brain natriuretic peptide (NT-proBNP) are released from myocardial cells in response to volume expansion and increased wall tension. They are well established rule-out tools for cardiac disease in unselected communities. NT-proBNP value <125 pg/mL excludes cardiac dysfunction with a high level of certainty in patients presenting with dyspnea. As the value increases heart failure becomes more likely. NT-proBNP levels are correlated with New York Heart Association (NYHA) functional classes for CHF. However, the role of natriuretic peptides extends beyond heart failure diagnosis; it is a clinical support tool in risk stratification & management in both inpatient and outpatient settings. Recent studies have shown that it can also be used for Cardiovascular risk assessment in asymptomatic patients with Type 2 Diabetes Mellitus.
₹2,800.00Original price was: ₹2,800.00.₹2,500.00Current price is: ₹2,500.00.
